FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387379285> ?p ?o ?g. }

• W4387379285 abstract "Abstract Disclosure: L.A. Gonzalez-Rodriguez: Research Investigator; Self; Eli Lilly & Company. I.C. Arroyo: None. B. Diaz-Rios: None. L. González-Sepúlveda: None. C.M. Casas-Loyola: None. J. Bermúdez-Santos: None. C. Pérez-Cardona: None. J. Romaguera: None. R. Azziz, MD, MBA, MPH: Advisory Board Member; Self; Arora Forge. Consulting Fee; Self; Rani Therapeutics, Spruce Biosciences, Fortress Biotech, Core Access Surgical Technologies. Grant Recipient; Self; Ferring Pharmaceuticals. Stock Owner; Self; Martin Imaging. PURPOSE: Polycystic Ovary Syndrome (PCOS), a common endocrinopathy affecting women in their reproductive years, is associated with an increased risk for cardiometabolic comorbidities. Even though PCOS is a common condition, there is often a delay in diagnosis and treatment due to several proposed diagnostic criteria. Due to the complexity of this syndrome and different clinical manifestations, it has been recommended to identify their 4 phenotypes. This study aimed to compare the clinical and metabolic characteristics among PCOS-phenotypes in a sample of Hispanic patients. METHODS: This is a cross-sectional study of females between 21-45 years of age with confirmed PCOS using the Rotterdam criteria. Patients were classified according to phenotypes: A, hyperandrogenism (HA), oligoovulation/menstrual dysfunction (OA/MD), and polycystic ovarian morphology (PCOM); B, HA + OA/MD; C, HA + PCOM; D, OA/MD + PCOM. Metabolic Syndrome (MetS) was diagnosed using ATP III criteria. Metabolic characteristics were compared between groups. RESULTS: Sixty-three patients with PCOS were evaluated with phenotypes A (60%), B (21%), C (5%), and D (14%). Only 26 patients (41%) had a previous diagnosis of PCOS. The prevalence of MetS in this sample was 52.4%. Among the phenotypes, phenotype B had the higher prevalence of MetS (61.5%) followed by phenotype D (55.6%) and phenotype A (52.6%). Significant differences in obesity, waist, and hip circumference were found, with phenotype-C having lower parameters (p ≤ 0.05). A tendency for lower BMI, waist-to-hip-ratio, HOMA-IR, and hs-CRP levels was also observed in phenotype-C. CONCLUSION: Our study found a high prevalence of MetS in this sample of patients with PCOS; phenotypes affected by menstrual dysregulation having a higher prevalence. Less than half of patients with PCOS were previously diagnosed despite multiple medical evaluations for symptoms, which emphasizes the importance of an early diagnosis to avoid cardiometabolic complications. Presentation: Thursday, June 15, 2023" @default.
• W4387379285 created "2023-10-06" @default.
• W4387379285 creator A5002359533 @default.
• W4387379285 creator A5021610863 @default.
• W4387379285 creator A5029600542 @default.
• W4387379285 creator A5043652848 @default.
• W4387379285 creator A5069955487 @default.
• W4387379285 creator A5077092188 @default.
• W4387379285 creator A5093011215 @default.
• W4387379285 creator A5093011216 @default.
• W4387379285 creator A5093011217 @default.
• W4387379285 date "2023-10-01" @default.
• W4387379285 modified "2023-10-16" @default.
• W4387379285 title "THU635 Metabolic Characteristics Among Polycystic Ovary Syndrome-Phenotypes In A Sample Of Hispanic Patients" @default.
• W4387379285 doi "https://doi.org/10.1210/jendso/bvad114.1539" @default.
• W4387379285 hasPublicationYear "2023" @default.
• W4387379285 type Work @default.
• W4387379285 citedByCount "0" @default.
• W4387379285 crossrefType "journal-article" @default.
• W4387379285 hasAuthorship W4387379285A5002359533 @default.
• W4387379285 hasAuthorship W4387379285A5021610863 @default.
• W4387379285 hasAuthorship W4387379285A5029600542 @default.
• W4387379285 hasAuthorship W4387379285A5043652848 @default.
• W4387379285 hasAuthorship W4387379285A5069955487 @default.
• W4387379285 hasAuthorship W4387379285A5077092188 @default.
• W4387379285 hasAuthorship W4387379285A5093011215 @default.
• W4387379285 hasAuthorship W4387379285A5093011216 @default.
• W4387379285 hasAuthorship W4387379285A5093011217 @default.
• W4387379285 hasBestOaLocation W43873792851 @default.
• W4387379285 hasConcept C126322002 @default.
• W4387379285 hasConcept C134018914 @default.
• W4387379285 hasConcept C2777391703 @default.
• W4387379285 hasConcept C2780186808 @default.
• W4387379285 hasConcept C2780578515 @default.
• W4387379285 hasConcept C29456083 @default.
• W4387379285 hasConcept C3018442814 @default.
• W4387379285 hasConcept C511355011 @default.
• W4387379285 hasConcept C71924100 @default.
• W4387379285 hasConceptScore W4387379285C126322002 @default.
• W4387379285 hasConceptScore W4387379285C134018914 @default.
• W4387379285 hasConceptScore W4387379285C2777391703 @default.
• W4387379285 hasConceptScore W4387379285C2780186808 @default.
• W4387379285 hasConceptScore W4387379285C2780578515 @default.
• W4387379285 hasConceptScore W4387379285C29456083 @default.
• W4387379285 hasConceptScore W4387379285C3018442814 @default.
• W4387379285 hasConceptScore W4387379285C511355011 @default.
• W4387379285 hasConceptScore W4387379285C71924100 @default.
• W4387379285 hasIssue "Supplement_1" @default.
• W4387379285 hasLocation W43873792851 @default.
• W4387379285 hasOpenAccess W4387379285 @default.
• W4387379285 hasPrimaryLocation W43873792851 @default.
• W4387379285 hasRelatedWork W2000231342 @default.
• W4387379285 hasRelatedWork W2017513128 @default.
• W4387379285 hasRelatedWork W2039741257 @default.
• W4387379285 hasRelatedWork W2186218348 @default.
• W4387379285 hasRelatedWork W2273379237 @default.
• W4387379285 hasRelatedWork W2434689181 @default.
• W4387379285 hasRelatedWork W2564128998 @default.
• W4387379285 hasRelatedWork W2564962018 @default.
• W4387379285 hasRelatedWork W3199496467 @default.
• W4387379285 hasRelatedWork W4256605237 @default.
• W4387379285 hasVolume "7" @default.
• W4387379285 isParatext "false" @default.
• W4387379285 isRetracted "false" @default.
• W4387379285 workType "article" @default.